Skip to main content
Download PDF

A Cryptosporidium parvum vaccine candidate effect on immunohistochemical profiling of CD4+, CD8+, Caspase-3 and NF-κB in mice

BMC Veterinary Research volume 19, Article number: 216 (2023) Cite this article

Abstract

Background

Cryptosporidium parvum is a protozoan parasite of medical and veterinary importance that causes neonatal diarrhea in many vertebrate hosts. In this study, we evaluated the efficacy of an affinity-purified antigen as a C. parvum vaccine candidate using ileal and liver tissues of experimentally infected neonatal mice by immunohistochemical profiling and immune scoring of CD4+, CD8+, Caspase-3, and nuclear factor kappa B (NF-κB). This vaccine was prepared from the C. parvum oocysts antigen using immune affinity chromatography with cyanogen bromide-activated Sepharose-4B beads.

Methods

Thirty neonatal mice were divided into three groups (10 mice/group): (1) non-immunized non-infected, (2) non-immunized infected (using gastric tubes with a single dose of 1 × 105 of C. parvum oocysts in 250 µl PBS solution 1 h before a meal) and (3) immunized (twice with 40 µg/kg of purified C. parvum antigen at 2-week intervals and then infected with 1 × 105 C. parvum oocysts simultaneously with the second group). After euthanizing the animals on the 10th day, post-infection, their ileal and liver tissues were collected and prepared for immunohistochemistry (IHC) staining to detect CD4+, CD8+, Caspase-3, and NF-κB levels, which are indicators for T helper cells, cytotoxic T cells, apoptosis, and inflammation, respectively.

Results

The IHC results showed that CD4+, CD8+, Caspase-3, and NF-κB expression varied significantly (P < 0.001) in both organs in all the groups. We also recorded high CD4+ levels and low CD8+ expression in the non-immunized non-infected mice tissues, while the opposite was observed in the non-immunized infected mice tissues. In the immunized infected mice, the CD4+ level was higher than CD8 + in both organs. While the Caspase-3 levels were higher in the ileal tissue of non-immunized infected than immunized infected mice ileal tissues, the reverse was seen in the liver tissues of both groups. Furthermore, NF-κB expression was higher in the liver tissues of non-immunized infected mice than in immunized infected mice tissues. Therefore, the IHC results and immune-scoring program revealed a significant difference (P < 0.001) in the CD4+, CD8+, Caspase-3, and NF-κB expression levels in both ileal and liver tissues of all mice groups, which might be necessary for immunomodulation in these tissues.

Conclusions

The improvement observed in the immunized infected mice suggests that this vaccine candidate might protect against cryptosporidiosis.

Peer Review reports

Background

Cryptosporidium parvum (C. parvum) is a ubiquitous apicomplexan parasite that mainly infects the gastrointestinal epithelium of humans and animals [1, 2]. It mainly inhabits the apical part of the epithelial cells and does not cause systemic infection or deep-tissue penetration [3, 4]. Additionally, cryptosporidiosis might extend into the biliary epithelium. As the parasite uses the host’s biological processes for its replication [5], the host’s epithelial cells are essential for its survival and protective immune responses [6].

Although the cell-mediated immune response to cryptosporidiosis is known to be via CD4+ T cells, the role of CD8+ T cells is not yet clear [7, 8]. Moreover, CD4+ T cells are important for the immune response to Cryptosporidium infection in both human and murine models [9]. CD4+ T cells and interferon-gamma (INF-γ) were found to be the dominant immune agents against murine C. parvum infection as the IFN-γ produced by these cells is required for infection clearance [9, 10]. Studies suggested that CD8+ T cells might contribute to the cell-mediated immune response against Cryptosporidium via direct cytolysis of the infected intestinal epithelial cells along with IFN-γ-mediated protection and clearance [11, 12]. Leav et al. [13] also demonstrated that CD8+ T cells are involved in early innate immunity in newborn mice.

As the intestinal mucosa is exposed to environmental antigens and pathogens, it contains multiple populations of innate and adaptive immune cells, such as the memory CD4+ T cells found throughout the organized intestinal lymphoid tissues, that contribute to many immune functions [14]. Additionally, CD4+ T cells are predominantly found location at the lymphoid tissues of the body, and they outnumber CD8+ T cells in mucosal tissues and barrier surfaces [15, 16]. In addition to their role in protective responses, they mediate potential in situ immune responses after collateral tissue damage, causing tissue-specific inflammatory disease. Therefore, the contribution of tissue-resident memory T-cell responses should be considered [17]. Host cell death after parasitic infection is represented by the tissue damage resulting from an immediate defense response against intracellular pathogens, such as C. parvum [18, 19]. During apoptosis, the cellular contents are packaged into apoptotic bodies, which are phagocytosed by other cells without a robust inflammatory response [20]. The key morphological changes of this process, mediated by caspases are irreversible [21]. Thus, Caspase activity must be regulated to prevent undesired host cell death [21, 22].

Parasites, including protozoans and helminthes, have developed evolutionary strategies that can interfere with cell death to survive and multiply inside the host tissues [23]. Many studies suggested that C. parvum has multiple strategies to control apoptosis to facilitate its growth and life cycle completion. Within a few hours of infection, C. parvum activates nuclear factor kappa B (NF-κB), which, in turn, activates the antiapoptotic mechanisms [24,25,26]. It has also been reported to limit host cell death [18]. During the later stages of infection, these antiapoptotic mechanisms disappear, causing host cell death [27]. The inhibition and induction of epithelial cell apoptosis are the underlying basis of the host-parasite interaction [8]. In vitro infection of human tumor cell lines showed that C. parvum only replicates in cells in which apoptosis is inhibited [25] due to NF-κB activation [24, 28]. However, the key components involved in the rescue from apoptosis might differ depending on the type of cells and parasites [29]. The invasion of intestinal and biliary epithelium by C. parvum-activated TLR4/MyD88/NF-κB signaling, in vitro, triggers the secretion of various cytokines and chemokines that can kill the parasite or inhibit its growth and induce the expression of pro- and anti-apoptotic factors [30].

Here, we evaluated an affinity-purified antigen as a vaccine candidate against C. parvum in experimentally infected neonatal mice. The efficacy of this vaccine was assessed using immunohistochemical (IHC) tests and immune scoring of CD4+, CD8+, Caspase-3, and NF-κB in the examined intestinal and liver tissues.

Results

IHC staining

The IHC results revealed the positive staining for CD4+ (Figs. 1 and 2) and CD8+ (Figs. 3 and 4) antibodies in the ileal and liver tissues of all groups. The negative control tissues, C. parvum-infected and the immunized infected groups showed mild, moderate, and high expression of CD4+ and CD8+, respectively.

Fig. 1
figure 1

Photomicrographs showing CD4+ antibody staining in the ileal tissue sections of the (a and d) negative control, (b and e) C. parvum-infected, and (c and f) immunized infected groups indicating mild, moderate, and high CD4+ expression, respectively (arrows). (CD4+ antibody, magnification: 100 × and 400 ×, respectively, scale bar: 200 and 50 μm, respectively)

Full size image
Fig. 2
figure 2

Photomicrographs showing CD4 + antibody reactivity in the liver tissue sections of (a and d) the negative control, (b and e) C. parvum-infected, and (c and f) immunized infected groups indicating mild, moderate, and highest reactivity to CD4+ antibody, respectively (arrows). (CD4+ Antibody, magnification: 100 × and 400 ×, respectively, Scale bar: 200 and 50 μm, respectively)

Full size image
Fig. 3
figure 3

Photomicrographs showing CD8+ antibody reactivity in the ileal tissue sections of (a and d) the negative control, (b and e) C. parvum-infected group, and (c and f) immunized infected group indicating mild, moderate, and intense positive expression of CD8+ antibody, respectively (arrows). (CD8+ Antibody, magnification: 100 × and 400 ×, respectively, Scale bar: 200 and 50 μm, respectively)

Full size image
Fig. 4
figure 4

Photomicrographs showing CD8+ antibody expression in the liver tissue sections of (a and d) the negative control, (b and e) C. parvum-infected, and (c and f) immunized infected groups indicating mild, moderate, and strong positive expression of CD8+ antibody, respectively (arrows). (CD8+ Antibody, magnification: 100 × and 400 ×, respectively, scale bar: 200 and 50 μm, respectively)

Full size image

Figure 5 showed the immune response of the ileal tissue sections to Caspase-3 antibodies in all groups. The negative control group showed mild Caspase-3 antibody expression, while the C. parvum-infected group exhibited the highest Caspase-3 reactivity among the examined groups. The immunized group showed moderate expression.

Fig. 5
figure 5

Photomicrographs displaying the Caspase-3 antibody expression in the ileal tissue sections of (a and d) the negative control, (b and e) C. parvum-infected, and (c and f) immunized infected groups indicating mild, highest, and moderate Caspase-3 antibody expression, respectively (arrows). (Caspase-3 Antibody, magnification: 10 × and 40 ×, respectively, scale bar: 200 and 50 μm, respectively)

Full size image

The liver tissue sections of the negative control and C. parvum-infected groups exhibited mild and moderate Caspase-3 expression, respectively (Fig. 6), while those in the immunized group showed the highest Caspase-3 antibody expression.

Fig. 6
figure 6

Photomicrographs showing the Caspase-3 antibody expression in the liver tissue sections of the (a and d) negative control, (b and e) C. parvum-infected, and (c and f) immunized infected groups showing scarce, moderate, and highest reactivity to the Caspase-3 antibody, respectively (arrows). (Caspase-3 Antibody, magnification: 10 × and 40 ×, respectively, Scale bar: 200 and 50 μm, respectively)

Full size image

Figures 7 and 8 showed the immune reactivity of the ileal and liver tissue sections to NF-κB antibody. The sections of the negative control and C. parvum-infected groups displayed mild and moderate reactivity to NF-κB antibody, while the immunized infected group showed the highest reactivity.

Fig. 7
figure 7

Photomicrographs showing the NF-κB antibody expression in the ileal tissue sections of the (a and d) negative control, (b and e) C. parvum-infected, and (c and f) immunized infected groups presenting mild, moderate, and highest reactivity to NF-κB antibodies, respectively (arrows). (NF-κB Antibody, magnification: 10 × and 40 ×, respectively, Scale bar; 200 and 50 μm, respectively)

Full size image
Fig. 8
figure 8

Photomicrographs showing NF-κB antibody expression in the liver tissue sections of the (a and d) negative control, (b and e) C. parvum-infected, and (c and f) immunized infected groups indicating mild cytoplasmic, moderate cytoplasmic, and highest nuclear reactivity to NF-κB antibodies (arrows). (NF-κB Antibody, Magnification: 10 × and 40 ×, respectively, Scale bar; 200 and

Full size image

Immune-scoring area % to CD4+, CD8+, Caspase-3, and NF-κB

The immune-scoring results for CD4+, CD8+, Caspase-3, and NF-κB antibodies indicated a significant difference (P < 0.001) between the tissue sections of all groups (Tables 1 and 2). We also noticed high CD4+ and low CD8+ expression levels in the non-infected non-immunized group, while the opposite was seen in the infected non-immunized mice. In the immunized infected mice, the CD4+ levels were back to being higher than CD8+ in both organs.

Table 1 Immune-scoring area % to CD 4, CD 8, Caspase-3, and NF-κB in the ileal tissues of the examined groups
Full size table
Table 2 Immune-scoring area % to CD 4, CD 8, Caspase-3, and NF-κB in the liver tissues of the examined groups
Full size table

Caspase-3 expression was higher in the ileal tissues of C. parvum-infected mice than in the immunized infected mice. Contrarily, it was higher in the liver tissues of immunized infected mice than in the C. parvum-infected tissues. NF-κB expression was higher in the C. parvum-infected ileal and liver tissues than in the immunized infected tissues.

Discussion

The affinity-purified C. parvum oocyst antigen used in our study was previously characterized by SDS-PAGE, Western blot, and amino acid analysis, and its diagnostic potential was evaluated by ELISA [31]. As a vaccine candidate, it successfully imparted protective cellular and humoral responses against C. parvum in mice, significantly decreasing oocyst shedding, histopathological changes, and parasite developmental stages in the tissues [32].

Here, we chose the ileum as it is most affected by cryptosporidiosis in mice [33] and the liver as it is continuously exposed to many environmental pathogens and stress [34]. We used IHC staining to detect CD4+, CD 8, Caspase-3, and NF-κB as markers for T helper cells, cytotoxic T cells, apoptosis, and inflammation, respectively, in healthy, C. parvum-infected, and immunized infected mice groups. The immune-scoring program results verified a significant difference (P < 0.001) in CD4+, CD8+, Caspase-3, and NF-κB expression i in both ileum and liver tissues of all the groups, which might be important for immunomodulation in these regions.

Regarding the immune-scoring percentage, we reported high CD4+ and low CD8+ expression in the non-infected non-immunized groups. This was consistent with Fahmy et al. [35], who found that healthy non-infected mice exhibited a higher intestinal expression of local CD4+ T cells than CD8+ Tcells. Tauschmann et al. [36] found high CD4+ and low CD8+ T-cell counts in the small and large intestines. Several experimental studies on Cryptosporidium have linked the cell-mediated immune responses, especially the CD4+ T count, to the susceptibility to infection and severity of the disease. Although CD4+ T cells and IFN-γ are known to be essential for the clearance of Cryptosporidium infection, CD8+ T cells and humoral responses might also be involved [8]. The severity of cryptosporidiosis depends on the extent of immunosuppression, as indicated by the CD4+ T count [37]. A balanced CD4+/CD8+ T cell ratio is important for evaluating the immunomodulation response and the homeostasis of the immune system [38]. Here, we observed the reverse as we found that more CD8 + cells than CD4+ T cells in the infected non-immunized mice. However, Fahmy et al. [35] demonstrated overexpression of CD8+ T over CD4+ T cells in the C. parvum-infected mice intestines, which reversed the balanced CD4+/CD8+ ratio. The C. parvum-infected mice exhibiting high CD8+ expression did not show improvement in either parasite load or pathological consequences, as the CD4+ and CD8+ T cells were observed on the 10th day of infection (when the oocysts shedding, and pathological lesions were high). This suggests that inadequate CD8+ T cells might hinder the elimination of cryptosporidiosis in murine models [39]. We observed high expression of both CD4+ and CD8+ in immunized infected mice, where the CD4+ counts were back to being higher than CD8+ in both organs. This finding, combined with lower oocyst shedding and pathological lesions in the immunized infected mice than the infected non-immunized ones on the 10th day post-infection (as previously shown by our study: Aboelsoued et al. [32], might suggest the protective effect of the vaccine candidate.

Tissue damage at parasitic infection sites indicates host cell death or apoptosis in response to an intracellular pathogen, such as C. parvum [18, 19]. Infected host cells might be eliminated by activating caspases and inducing apoptosis to limit the spread of infection [40]. We observed mildly positive Caspase-3 expression in non-immunized non-infected mice tissues, consistent with Samaka et al. [41], who found low Caspase immunostaining levels in the absorptive epithelial cells. Also, we found that the immune scoring of Caspase-3 was higher in the ileal tissue of C. parvum-infected than in non-infected tissues, indicating signs of infection-induced apoptosis. These findings agreed with Sasahara et al. [42], who reported apoptosis in the ileum of neonatal mice after C. parvum infection and assumed that epithelial apoptosis might be integral for C. parvum pathogenesis. Moreover, Buret et al. [43] found that experimental C. andersoni, infecting human and bovine epithelial cells, can promote host cell apoptosis. Host cell apoptosis was also reported due to infection with Trypanosoma cruzi, Toxoplasma gondii, Eimeria tenella, and Leishmania, which is considered a host defense strategy [29, 44, 45].

Here, we observed moderate Caspase-3 expression in the ileal tissues of the immunized infected group, which was less than in C. parvum-infected non-immunized tissues, indicating the protective effect of our vaccine against apoptosis. Contrastingly, the Caspase-3 expression was higher in the liver tissues of immunized infected mice than in C. parvum-infected tissues, probably due to the stress associated with the Freund’s adjuvant used. However, this adjuvant might improve the effect of immunization in experiments and veterinary medicine as it initiates oxidative stress and inflammation in mice [46] and produces a strong and long-lasting inflammatory reaction [47]. Therefore, mixing vaccines with adjuvants enhances antigen-specific immunity, producing reactive oxygen species, which leads to apoptosis through factors such as Caspase-3 activation [48].

Mele et al. [25] showed the activation of apoptosis at the sporozoite and merozoite stages and inhibition of host cell apoptosis at the trophozoite stage after C. parvum infection in vitro, suggesting that the parasite might interact with host cells and regulate its gene expression. This supports the assumption that the modulation of the host cell apoptosis depends on the Cryptosporidium stage [49], as C. parvum-infected cells show signs of apoptosis shortly after the invasion and during the late infection stages. However, significant blockage of the apoptotic response is accompanied by parasite replication within the infected cells [25]. The C. parvum infection is considered to interfere with the temporal progression of the normal apoptotic response by delaying it sufficiently to help parasite replication. When the parasite becomes ready to exit the cell after replication, it either induces apoptosis or allows the cell to continue along its path, which is initiated during the early infection phases [24, 25].

We found that the NF-κB expression was higher in the ileum and liver tissues of C. parvum-infected mice than in non-infected ones, which might be supported by the hypothesis that C. parvum can neutralize the immediate cellular apoptosis response to sustain the infection and allow life cycle progression [18, 24]. Also, the inhibition of NF-κB enhanced C. parvum-induced apoptosis was observed in intestinal epithelial cells in vitro [18]. Furthermore, NF-κB activation-related protection against apoptosis in the infected cells had also been shown in other apicomplexan parasitic infections [29], such as Toxoplasma gondii [50] and Theileria parva [51] suggesting that this is possibly a common characteristic of these parasites.

In this study, NF-κB expression was lower in the immunized C. parvum-infected ileal and liver mice tissues than in the infected mice tissues, which might indicate the protective effect of our candidate vaccine against inflammation. This is consistent with our previous study, where we showed that immunized C. parvum-infected tissues displayed a slight pathogenic effect than non-immunized infected tissues [32]. This also agreed with Shang et al. [52], who found that vaccination suppressed NF-κB expression in the mucosal epithelium tissues and hence, blocked the inflammatory response. This vaccine-induced inhibitory mechanism might indicate how epithelium responds differentially to new or previously encountered pathogens. We showed a higher NF-κB profile in C. parvum-infected ileal and liver mice tissues than immunized infected mice tissues, measured as area % in a standard measuring frame Leica scoring program. This contradicts the IHC staining photomicrographs (Figs. 7 and 8) in which NF-κB expression was higher in the ileal and liver tissues of immunized infected mice than in C. parvum-infected mice tissues, indicating a possible nonspecific reaction in the C. parvum-infected tissues.

Conclusion

Developing effective vaccines against cryptosporidiosis requires a better understanding of both the parasite and host immune responses. Our IHC staining results, evaluated using an immune-scoring program, showed that CD4+, CD8+, Caspase-3, and NF-κB profiles might be important for immunomodulation in the ileal and liver tissues. We observed improvement in immunized infected mice, indicating that the prepared vaccine candidate might effectively protect against cryptosporidiosis. Further studies using different animal hosts and adjuvants are warranted for getting a deep understanding the efficacy of this vaccine at the molecular level.

Materials and methods

Animals

Mice

We obtained seven pregnant laboratory-bred Swiss albino mice from the animal house at the National Research Centre, Egypt, and adapted them to the experimental conditions for a week. All the pregnant mice were confirmed to be parasite-free by fecal examination for three consecutive days using flotation, sedimentation and modified Ziehl Neelsen (MZN) techniques [53] before starting experiments. The experimental area was strictly sanitized. Food and water were provided ad libitum. On day 3 after birth, 30 newborn mice were randomly divided into groups for experiments.

Rabbits

We used five male New Zealand rabbits aging six weeks and weighing 1.5–2 kg. The rabbits were purchased from local poultry markets and we cannot obtained informed consent from the owner. These rabbits were confirmed to be parasite-free by fecal examination for three consecutive days using flotation, sedimentation and MZN techniques [53] before starting experiments. After adapting to the experimental conditions for a week, the animals were given food and water ad libitum under strict, sanitized conditions.

Parasite

We used the C. parvum isolate (GenBank ON730707) that was previously identified using the Cryptosporidium oocyst wall protein (COWP) gene by PCR from fecal samples collected from ten newborn buffalo calves (aging 10–20 days) reared by local farmers in Beni-Suef Governorate, Egypt [32]. The authors confirm that permission from the farmer was obtained for collecting fecal samples from newborn buffalo calves.

Experimental design

Propagation of oocysts

To produce more oocysts for preparing the C. parvum oocysts antigen, ten parasite-free neonatal Swiss albino mice (three days of age) were experimentally infected using a single dose of 1 × 105 C. parvum oocysts collected from naturally infected buffalo calves using gastric tubes 1 h before a meal [54]. After three days, the fecal pellets were collected daily for three weeks and examined using the MZN technique [53]. Then, the oocysts were concentrated by centrifuging (500 ×g) using Sheather’s sugar solution [55] and preserved in potassium dichromate solution (2.5%) at 4°C. Before experimental infection into mice, they were washed by phosphate buffered saline (0.01 M, pH 7.2), concentrated, and counted using a hemocytometer [56].

Preparation of oocysts antigen

C. parvum oocyst antigen was prepared by sonication (Sonics Vibra-Cell VCX750 USA; 12 cycles/30 seconds and then centrifuged at 12,000 ×g for 15 min at 4°C) after 20 freeze-thaw cycles according to Aboelsoued et al. [57].

Preparation of rabbit hyperimmune serum

The rabbit hyperimmune serum against the C. parvum oocyst antigen was prepared according to Fagbemi et al. [58]. After collecting the blood samples from the rabbit’s ear vein, the sera were separated and stored at − 20°C until further use. After preparation of the hyperimmune serum in the experiment, the rabbits used were not euthanized and released.

Affinity purification of C. parvum oocyst soluble antigen

The prepared rabbit hyperimmune serum was defrosted and dialyzed for three days in a coupling buffer and then coupled to cyanogen bromide-activated Sepharose-4B (Sigma Aldrich) (2 mg/ml-swollen beads) according to the manufacturer’s protocol. The C. parvum oocyst antigen was applied to the affinity column (Flex-Column, Kimble, USA) as described by Toaleb et al. [59]. The bound fraction was eluted using the elution buffer. The protein content of the purified antigen was estimated using the Lowry’s method [60]. and stored at − 20°C until use.

Mice immunization

The parasite-free pregnant laboratory-bred Swiss albino mice were obtained and adapted to the experimental conditions for a week. Three-day-old newborn mice were randomly divided into three groups (10 mice/group). The first group was the negative control, and the 2nd group (positive control) was experimentally infected orally with a dose of 1 × 105 isolated C. parvum oocysts in 250 µl PBS solution (pH 7.2) [54] using gastric tubes 1 h before a meal. In the 3rd group, the mice were injected subcutaneously with 40 µg/kg of the C. parvum purified fraction (as a vaccine) emulsified in complete Freund’s adjuvant for primary immunization [61]. After two weeks, a booster dose containing another 40 µg/kg of the same purified fraction in incomplete Freund’s adjuvant was administered. Two weeks after the booster each mouse was infected orally by 1 × 105 C. parvum oocysts, and the positive control group was experimentally infected simultaneously. All mice were euthanized on the 10th day post-infection (at the peak of oocysts shedding) by cervical dislocation under anesthesia with using intra-peritoneal injection of sodium pentobarbital at dose of 40 to 50 mg/kg [32]. The small intestine (ileum) and liver tissues were collected from all the mice and fixed in 10% neutral buffered formalin for 24 h. Then, they were trimmed, washed, dehydrated, cleared in xylene, and embedded in paraffin wax, as described by Bancroft and Stevens [62].

Immunohistochemistry (IHC) staining

IHC was performed using the paraffin sections mounted on positively charged slides to detect CD4+, CD8+, Caspase-3, and NF-κB expression as indicators of T helper cells, cytotoxic T cells, apoptosis, and inflammation using the avidin-biotin-peroxidase complex (ABC) method [63]. Polyclonal anti-CD4+ (1:50–1:200, Quartett, Cat# CD024-02), monoclonal anti-CD8+ antibody (C8/144B, 1:25–1:100, Quartett, Cat# CD039-10), polyclonal antiactive Caspase-3 (cleaved form, 1:50–1:100, Sigma Diagnostic Biosystems, Cat# RP096) and monoclonal anti-NF-κB2 (Sigma Aldrich, Cat# AMAB91511) were used. The ileum and liver sections from each group were incubated with the above mentioned antibodies, and the reagents required for the ABC method (Vectastain ABC-HRP kit, Vector laboratories) were added. Marker expression was labeled with peroxidase and colored with diaminobenzidine (DAB, Sigma) to detect the antigen-antibody complex. The negative control consisted of a nonimmune serum instead of primary or secondary antibodies. The stained sections were examined under a microscope (CH9435 Hee56rbrugg, Leica Microsystems, Switzerland).

Evaluation of IHC results in terms of “area percentage” (specific area/Antibody)

The areas displaying positive brown immunostaining were evaluated regardless of the staining intensity using some features (cell counter, color deconvolution, color threshold, and IHC plugin) of the Leica scoring program. The measurement units (pixels) were converted into actual micrometer units. CD4+, CD8+, Caspase-3, and NF-κB immunostaining were measured as area % in a standard measuring frame, representing six fields for each subject (ileum and liver) in all groups under 400x magnification.

Statistical analysis

Statistical analysis was performed with SPSS 19.0 for Windows (Statistical Package for Scientific Studies, SPSS, Inc., USA). The values were represented as mean and standard error. The immune-scoring data was tested for normality via the Kolmogorov-Smirnov test of normality, whose outcomes indicated that the highest data were normally distributed (parametric data). Thus, one way-analysis of variance (ANOVA) and post-hoc tests were used to compare the groups. Values with P < 0.05 were considered statistically significant.

Data Availability

The database used or analyzed during this study are available from the corresponding author on reasonable request.

Abbreviations

C. parvum :

Cryptosporidium parvum

IHC :

Immunohistochemical

SPSS:

Statistical Package for Social Sciences

ANOVA :

Analysis of Variance

References

  1. Ghazy AA, Abdel-Shafy S, Shaapan RM. Cryptosporidiosis in animals and man: 1. Taxonomic classification, life cycle, epidemiology and zoonotic importance. As J Epidemiol. 2015;8(3):48–63. https://0-doi-org.brum.beds.ac.uk/10.3923/aje.2015.48.63

    Article  Google Scholar 

  2. Aboelsoued D, Abdel Megeed KN. Diagnosis and control of cryptosporidiosis in farm animals. J Parasit Dis. 2022;46:1133–46. https://0-doi-org.brum.beds.ac.uk/10.1007/s12639-022-01513-2

    Article  PubMed  Google Scholar 

  3. Ghazy AA, Abdel-Shafy S, Shaapan RM. Cryptosporidiosis in animals and man: 3. Prev Control as J Epidemiol. 2016;9(1–3):1–9. https://0-doi-org.brum.beds.ac.uk/10.3923/aje.2016.1.9

    Article  Google Scholar 

  4. Gaber M, Galal LAA, Hassan D, Badary DM, et al. Evidences of brain and lung invasion of a local water Cryptosporidium parvum isolate in comparison to Iowa strain: serological and immunohistochemical cytokine evaluation. Ann Parasitol. 2020;66(3):311–8. https://0-doi-org.brum.beds.ac.uk/10.17420/ap6603.269

    Article  PubMed  Google Scholar 

  5. Deng M, Rutherford MS, Abrahamsen MS. Host intestinal epithelial response to Cryptosporidium parvum. Adv Drug Deliv Rev. 2004;56(6):869–84. https://0-doi-org.brum.beds.ac.uk/10.1016/j.addr.2003.10.034

    Article  CAS  PubMed  Google Scholar 

  6. Laurent F, Lacroix-Lamandé S. Innate immune responses play a key role in controlling infection of the intestinal epithelium by Cryptosporidium. Int J Parasitol. 2017;47:711–21. https://0-doi-org.brum.beds.ac.uk/10.1016/j.ijpara.2017.08.001

    Article  CAS  PubMed  Google Scholar 

  7. Riggs MW. Recent advances in cryptosporidiosis: the immune response. Microbes Infect. 2002;4(10):1067–80. https://0-doi-org.brum.beds.ac.uk/10.1016/s1286-4579(02)01631-3

    Article  CAS  PubMed  Google Scholar 

  8. Ludington JG, Ward HD. Systemic and mucosal immune responses to cryptosporidium—vaccine development. Curr Trop Med Rep. 2015;2(3):171–80. https://0-doi-org.brum.beds.ac.uk/10.1007/s40475-015-0054-y

    Article  PubMed  PubMed Central  Google Scholar 

  9. O’Hara SP, Bogert PS, Trussoni CE, Chen X, LaRusso NF. TLR4 promotes Cryptosporidium parvum clearance in a mouse model of biliary cryptosporidiosis. J Parasitol. 2011;97(5):813–21. https://0-doi-org.brum.beds.ac.uk/10.1645/GE-2703.1

    Article  CAS  PubMed  Google Scholar 

  10. Gomez Morales MA, Mele R, Ludovisi A, Bruschi F, Tosini F, Pozio E. Cryptosporidium parvum-specific CD4+ Th1 cells from sensitized donors responding to both fractionated and recombinant antigenic proteins. Infect Immun. 2004;72(3):1306–10. https://0-doi-org.brum.beds.ac.uk/10.1128/IAI.72.3.1306-1310.2004

    Article  CAS  PubMed  Google Scholar 

  11. Pantenburg B, Castellanos-Gonzalez A, Dann SM, Connelly RL, Lewis DE, Ward HD, White AC Jr. Human CD8+ T cells clear Cryptosporidium parvum from infected intestinal epithelial cells. The Am J Trop Med Hyg. 2010;82(4):600–7. https://0-doi-org.brum.beds.ac.uk/10.4269%2Fajtmh.2010.09-0590.

    Article  CAS  PubMed  Google Scholar 

  12. Kváč M, Kodadkova A, Sak B, Kvetonova D, Jalovecka M, Rost M, et al. Activated CD8+ T cells contribute to clearance of gastric Cryptosporidium muris infections. Parasite Immunol. 2011;33(4):210–6. https://0-doi-org.brum.beds.ac.uk/10.1111/j.1365-3024.2010.01271.x

    Article  CAS  PubMed  Google Scholar 

  13. Leav BA, Yoshida M, Rogers K, Cohen S, Godiwala N, Blumberg RS, Ward H. An early intestinal mucosal source of gamma interferon is associated with resistance to and control of Cryptosporidium parvum infection in mice. Infect Immun. 2005;73(12):8425–8. https://0-doi-org.brum.beds.ac.uk/10.1128/IAI.73.12.8425-8428.2005

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Shale M, Schiering C, Powrie F. CD4(+) T-cell subsets in intestinal inflammation. Immunol Rev. 2013;252(1):164–82. https://0-doi-org.brum.beds.ac.uk/10.1111/imr.12039

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Sathaliyawala T, Kubota M, Yudanin N, Turner D, Camp P, Thome JJ, et al. Dis- tribution and compartmentalization of human circulating and tissue-resident memory T cell subsets. Immunity. 2013;38(1):187–97. https://0-doi-org.brum.beds.ac.uk/10.1016/j.immuni.2012.09.020

    Article  CAS  PubMed  Google Scholar 

  16. Turner DL, Bickham KL, Thome JJ, Kim CY, D’Ovidio F, Wherry EJ et al. Lung niches for the generation and maintenance of tissue-resident memory T cells. Mucosal Immunol 2014.7(3):501–10. https://0-doi-org.brum.beds.ac.uk/10.1038/mi.2013.67

  17. Turner DL, Farber DL. Mucosal resident memory CD4+ T cells in protection and immunopathology. Front Immunol. 2014;14(5):331. https://0-doi-org.brum.beds.ac.uk/10.3389/fimmu.2014.00331

    Article  CAS  Google Scholar 

  18. McCole DF, Eckmann L, Laurent F, Kagnoff MF. Intestinal epithelial cell apoptosis following Cryptosporidium parvum infection. Infect Immun. 2000;68(3):1710–3. https://0-doi-org.brum.beds.ac.uk/10.1128/IAI.68.3.1710-1713.2000

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Green DR. Apoptotic pathways: ten minutes to dead. Cell. 2005;121(5):671–4. https://0-doi-org.brum.beds.ac.uk/10.1016/j.cell.2005.05.019

    Article  CAS  PubMed  Google Scholar 

  20. Liu J, Enomoto S, Lancto CA, Abrahamsen MS, Rutherford MS. Inhibition of apoptosis in Cryptosporidium parvum-infected intestinal epithelial cells is dependent on survivin. Infect Immun. 2008;76(8):3784–92. https://0-doi-org.brum.beds.ac.uk/10.1128/IAI.00308-08

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Shi Y. Caspase activation: revisiting the induced proximity model. Cell. 2004; 25;117(7):855-8. https://0-doi-org.brum.beds.ac.uk/10.1016/j.cell.2004.06.007

  22. Goyal L. Cell death inhibition: keeping caspases in check. Cell. 2001;104(6):805–8. https://0-doi-org.brum.beds.ac.uk/10.1016/S0092-8674(01)00276-8

    Article  CAS  PubMed  Google Scholar 

  23. Bosurgi L, Rothlin CV. Management of cell death in parasitic infections. Semin Immunopathol. 2021;43(4):481–92. https://0-doi-org.brum.beds.ac.uk/10.1007/s00281-021-00875-8

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Chen XM, Levine SA, Splinter PL, Tietz PS, Ganong AL, Jobin C, Gores GJ, Paya CV, LaRusso NF. Cryptosporidium parvum activates nuclear factor κB in biliary epithelia preventing epithelial cell apoptosis. Gastroenterology. 2001;120(7):1774–83. https://0-doi-org.brum.beds.ac.uk/10.1053/gast.2001.24850

    Article  CAS  PubMed  Google Scholar 

  25. Mele R, Gomez Morales MA, Tosini F, Pozio E. Cryptosporidium parvum at different developmental stages modulates host cell apoptosis in vitro. Infect Immun. 2004;72(10):6061–7. https://0-doi-org.brum.beds.ac.uk/10.1128/IAI.72.10.6061-6067.2004

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Orange JS, Levy O, Geha RS. Human disease resulting from gene mutations that interfere with appropriate nuclear factor-κB activation. Immunol Rev. 2005;203(1):21–37. https://0-doi-org.brum.beds.ac.uk/10.1111/j.0105-2896.2005.00221.x

    Article  CAS  PubMed  Google Scholar 

  27. Liu J, Deng M, Lancto CA, Abrahamsen MS, Rutherford MS, Enomoto S. Biphasic modulation of apoptotic pathways in Cryptosporidium parvum-infected human intestinal epithelial cells. Infect Immun. 2009;77(2):837–49. https://0-doi-org.brum.beds.ac.uk/10.1128/IAI.00955-08

    Article  CAS  PubMed  Google Scholar 

  28. Lalaoui N, Vaux DL. Recent advances in understanding inhibitor of apoptosis proteins. F1000Research. 2018;F1000Res(7). https://0-doi-org.brum.beds.ac.uk/10.12688%2Ff1000research.16439.1.

  29. Carmen JC, Sinai AP. Suicide prevention: disruption of apoptotic pathways by protozoan parasites. Mol Microbiol. 2007;64(4):904–. https://0-doi-org.brum.beds.ac.uk/10.1111/j.1365-2958.2007.05714.x. 16.

    Article  CAS  PubMed  Google Scholar 

  30. O’Hara SP, Chen XM. The cell biology of Cryptosporidium infection. Microbes Infect. 2011;13(8–9):721–30. https://0-doi-org.brum.beds.ac.uk/10.1016/j.micinf.2011.03.008

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Aboelsoued D, Hendawy S, Abdullah HH, Abdel Megeed KN, Hassan SE, El Hakim AE, Toaleb NI. Diagnosis of Cryptosporidiosis using Affinity purified Antigen. Egyp J Vet Sci. 2022;53(3):459–73. https://0-doi-org.brum.beds.ac.uk/10.21608/ejvs.2022.145814.1354

    Article  Google Scholar 

  32. Aboelsoued D, Abdullah HHAM, Abdel Megeed KN, Hassan SE, Toaleb NI. Evaluation of a vaccine candidate isolated from Cryptosporidium parvum oocyst in mice. Accepted: Vet. World; 2022a.

    Book  Google Scholar 

  33. Aly I, Taher H, El-Feky F. Efficacy of low and high dose of paromomycin sulfate for treatment of cryptosporidiosis in immunosuppressed infected-mice. Glob Vet. 2015;15:137–43. https://www.idosi.org/gv/gv15(2)15/1.pdf

    CAS  Google Scholar 

  34. Leone V, Ali A, Weber A, Tschaharganeh DF, Heikenwalder M. Liver inflammation and hepatobiliary cancers. Trends Cancer. 2021;7606–23. https://0-doi-org.brum.beds.ac.uk/10.1016/j.trecan.2021.01.012

  35. Fahmy MEA, Abdelaal AA, Hassan SI, Shalaby MA, et al. Antiparasitic and immunomodulating effects of nitazoxanide, ivermectin and selenium on Cryptosporidium infection in diabetic mice. Braz J Vet Parasitol. 2021;30(4):e012121. https://0-doi-org.brum.beds.ac.uk/10.1590/S1984-29612021087

    Article  CAS  Google Scholar 

  36. Tauschmann M, Prietl B, Treiber G, Gorkiewicz G, et al. Distribution of CD4+ pos - CD8+ pos and regulatory T cells in the upper and lower gastrointestinal tract in healthy young subjects. PLoS ONE. 2013;8(11):e80362. https://0-doi-org.brum.beds.ac.uk/10.1371/journal.pone.0080362

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Tinarwo P, Zewotir T, North D. Trends and adaptive optimal set points of CD4+ count clinical covariates at each phase of the HIV disease progression. Aids Res Treat. 2020;2020:1379676. https://0-doi-org.brum.beds.ac.uk/10.1155/2020/1379676

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Wang Z, Wang Y, Xu B, Liu J, et al. Vitamin D improves immune function in immunosuppressant mice induced by glucocorticoid. Biomed Rep. 2017;6(1):120–24. https://0-doi-org.brum.beds.ac.uk/10.3892/br.2016.817

    Article  CAS  PubMed  Google Scholar 

  39. Tessema TS, Dauber E, Petry F. Adoptive transfer of protective immunity from Cryptosporidium parvum-infected interferon-γ and interleukin-12-deficient mice to naive recipients. Vaccine. 2009;27(47):6575–81. https://0-doi-org.brum.beds.ac.uk/10.1016/j.vaccine.2009.08.036

    Article  CAS  PubMed  Google Scholar 

  40. Uchiyama R, Tsutsui H. Caspases as the key effectors of inflammatory responses against bacterial infection. Arch Immunol Ther Exp. 2015;63(1):1–3. https://0-doi-org.brum.beds.ac.uk/10.1007/s00005-014-0301-2

    Article  CAS  Google Scholar 

  41. Samaka RM, El Shafei OK, Harba NM, Farag SA, Sharaf OF. Role of apoptosis in experimental Cryptosporidium parvum infected albino mice. Journal of the Egyptian Society of Parasitology. 2021;51(1):89–98. https://jesp.journals.ekb.eg/article_165944_dbb99eb2b35c8c8885e67d8bd6cdd9c9.pdf.

  42. Sasahara T, Sekiguchi T, Satoh Y, Kitasato H, Inoue M, Takayama Y, Takahashi A, Maruyama H, Aoki M, Kikuno R. Apoptosis of intestinal crypt epithelium after Cryptosporidium parvum infection. J Infect Chemother. 2003;9(3):278–81. https://0-doi-org.brum.beds.ac.uk/10.1007/s10156-003-0259-1

    Article  PubMed  Google Scholar 

  43. Buret AG, Chin AC, Scott KG. Infection of human and bovine epithelial cells with Cryptosporidium andersoni induces apoptosis and disrupts tight junctional ZO-1: effects of epidermal growth factor. Int J Parasitol. 2003;33(12):1363–71. https://0-doi-org.brum.beds.ac.uk/10.1016/S0020-7519(03)00138-3

    Article  CAS  PubMed  Google Scholar 

  44. Payne TM, Molestina RE, Sinai AP. Inhibition of caspase activation and a requirement for NF-kappa B function in the Toxoplasma gondii-mediated blockade of host apoptosis. J Cell Sci. 2003;116(21):4345–58. https://0-doi-org.brum.beds.ac.uk/10.1242/jcs.00756

    Article  CAS  PubMed  Google Scholar 

  45. Zhang L, Zheng MX, Xi R, Xu ZY, Zhang XS, Zheng LL, Bai R, Mi CL, Hao FF, Feng YP. Comparison of the host cells apoptosis induced by precocious strains and virulent strains of Eimeria tenella. Poult Sci. 2019;98(10):4384–90. https://0-doi-org.brum.beds.ac.uk/10.3382/ps/pez218

    Article  CAS  PubMed  Google Scholar 

  46. Pohanka M, Vobornikova I, Fusek J. Freund´s complete adjuvant effect on BALB/c mice: an insight into inflammation and oxidative stress after immunity challenge. Bratisl Lek Listy. 2016;117(5):268–71. https://0-doi-org.brum.beds.ac.uk/10.4149/bll_2016_052

    Article  CAS  PubMed  Google Scholar 

  47. Billiau A, Matthys P. Modes of action of Freund’s adjuvants in experimental models of autoimmune diseases. J Leukoc Biol. 2001;70(6):849–60. https://0-doi-org.brum.beds.ac.uk/10.1189/jlb.70.6.849

    Article  CAS  PubMed  Google Scholar 

  48. Loison E, Poirier-Beaudouin B, Seffer V, Paoletti A, Abitbol V, Tartour E, Launay O, Gougeon ML. Suppression by thimerosal of ex-vivo CD4+ T cell response to influenza vaccine and induction of apoptosis in primary memory T cells. PLoS ONE. 2014;9(4):e92705. https://0-doi-org.brum.beds.ac.uk/10.1371/journal.pone.0092705

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  49. Kolářová I, Valigurová A. Hide-and-Seek: a game played between parasitic Protists and their hosts. Microorganisms. 2021;9(12):2434. https://0-doi-org.brum.beds.ac.uk/10.3390/microorganisms9122434

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  50. Carmen JC, Hardi L, Sinai AP. Toxoplasma gondii inhibits ultraviolet light-induced apoptosis through multiple interactions with the mitochondrion-dependent programmed cell death pathway. Cell Microbiol. 2006;8(2):301–15. https://0-doi-org.brum.beds.ac.uk/10.1111/j.1462-5822.2005.00622.x

    Article  CAS  PubMed  Google Scholar 

  51. Guergnon J, Dessauge F, Langsley G, Garcia A. Apoptosis of Theileria-infected lymphocytes induced upon parasite death involves activation of caspases 9 and 3. Biochimie. 2003;85(8):771–6. https://0-doi-org.brum.beds.ac.uk/10.1016/j.biochi.2003.09.013

    Article  CAS  PubMed  Google Scholar 

  52. Shang L, Smith A, Reilly C, et al. Vaccine-modified NF-kB and GR signaling in cervicovaginal epithelium correlates with protection. Mucosal Immunol. 2018;11:512–22. https://0-doi-org.brum.beds.ac.uk/10.1038/mi.2017.69

    Article  CAS  PubMed  Google Scholar 

  53. Henriksen SA, Pohlenz JF. Staining of Cryptosporidia by a modified Ziehl-Neelsen technique. Acta Vet Scand. 1981;22:594–6. https://0-doi-org.brum.beds.ac.uk/10.1186/BF03548684

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  54. Aboelsoued D, Abo-Aziza FAM, Mahmoud MH, Abdel Megeed KN, et al. Anticryptosporidial effect of pomegranate peels water extract in experimentally infected mice with special reference to some biochemical parameters and antioxidant activity. J Parasit Dis. 2019;43(2):215–28. https://0-doi-org.brum.beds.ac.uk/10.1007/s12639-018-01078-z

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  55. Hassanain MA, Khalil FA, Abd El-Razik KA, Shaapan RM. Prevalence and molecular discrimination of Cryptosporidium parvum in calves in behira provinces, Egypt. Res J Parasitol. 2011;6(3):101–8. https://jp.2011.101.108

    Article  CAS  Google Scholar 

  56. Shaapan RM, Abdel-Ghaffar FA, Varjabedian KG, Saad-Alla GI. Prevalence and molecular epidemiology of Cryptosporidium infection in Clarias gariepinus fish in Egypt. Acta Parasitol. 2022;67(1):437–45. https://0-doi-org.brum.beds.ac.uk/10.1007/s11686-021-00483-4

    Article  CAS  PubMed  Google Scholar 

  57. Aboelsoued D, Hendawy SHM, Abo-Aziza FAM, Abdel Megeed KN. Copro-microscopical and immunological diagnosis of cryptosporidiosis in egyptian buffalo-calves with special reference to their cytokine profiles. J Parasit Dis. 2020;44(3):654–60. https://0-doi-org.brum.beds.ac.uk/10.1007/s12639-020-01244-2

    Article  PubMed  PubMed Central  Google Scholar 

  58. Fagbemi BO, Obarisiaghon IO, Mbuh JV. Detection of circulating antigen in sera of Fasciola gigantica infected cattle with antibodies reactive with a Fasciola-specific 88 kDa antigen. Vet Parasitol. 1995;58(3):235–46. https://0-doi-org.brum.beds.ac.uk/10.1016/0304-4017(94)00718-r

    Article  CAS  PubMed  Google Scholar 

  59. Toaleb NI, Gabr HSM, Abd El-Shafy S, Abdel-Rahman EH. Evaluation of vaccine candidates purified from the adult ticks of Ornithodoros savignyi (Acari: Argasidae) and Hyalomma dromedarii (Acari: Ixodidae) against tick infestations. J Parasit Dis. 2019;43(2):246–55. https://0-doi-org.brum.beds.ac.uk/10.1007/s12639-018-01082-3

    Article  PubMed  PubMed Central  Google Scholar 

  60. Lowry OH, Rosebrough NJ, Farr AB, Randall RJ. Protein measurement with the folin-phenol reagent. J Biol Chem. 1951;193:265–75.

    Article  CAS  PubMed  Google Scholar 

  61. Liu K, Zai D, Zhang D, Wei Q, Han G, Gao H, Huang B. Divalent Cp15-23 vaccine enhances immune responses and protection against Cryptosporidium parvum infection. Parasite Immunol. 2010;32(5):335–44. https://0-doi-org.brum.beds.ac.uk/10.1111/j.1365-3024.2009.01191.x

    Article  CAS  PubMed  Google Scholar 

  62. Bancroft JD, Stevens A. Theory and Practice of histological techniques. Churchill Livingstone, London. Edition: 2013;7th. Ed. P: 120:131.

  63. Hsu SM, Raine L, Fanger H. The use of antiavidin antibody and avidin-biotin-peroxidase complex in immunoperoxidase technics. Am J Clin Pathol. 1981;75(6):816–21. https://0-doi-org.brum.beds.ac.uk/10.1093/ajcp/75.6.816

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

Authors acknowledge the project grant No.: 12010136, funded by National Research Centre (NRC), Egypt.

Funding

This research was partially funded by the project grant No.: 12010136, funded by National Research Centre (NRC), Egypt. Another part was self-funding.

Open access funding provided by The Science, Technology & Innovation Funding Authority (STDF) in cooperation with The Egyptian Knowledge Bank (EKB).

Author information

Authors and Affiliations

  1. Department of Parasitology and Animal Diseases, Veterinary Research Institute, National Research Centre, El Buhouth Street, Dokki, Cairo, Egypt

    Dina Aboelsoued, Nagwa I. Toaleb & Kadria N. Abdel Megeed

  2. Department of Animal Reproduction and AI, Veterinary Research Institute, National Research Centre, El Buhouth Street, Dokki, Cairo, Egypt

    Sally Ibrahim

  3. Department of Zoonotic Diseases, Veterinary Research Institute, National Research Centre, P.O. 12622, El Buhouth Street, Dokki, Cairo, Egypt

    Raafat M. Shaapan

Authors
  1. Dina Aboelsoued
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nagwa I. Toaleb
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sally Ibrahim
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Raafat M. Shaapan
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Kadria N. Abdel Megeed
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

D.A, R.S. and N.I. wrote the main manuscript text, N.I., S.I. and K.N. prepared antigens and hyperimmune sera, D.A.,R.M. and S.I.and all authors reviewed and approved the final manuscript.

Corresponding author

Correspondence to Raafat M. Shaapan.

Ethics declarations

Ethics approval and consent to participate

All the experimental procedures were approved and carried out following the guidelines and of the International Animal Ethics Committee and the National Research Centre (NRC) guidelines of the Animal Research Committee under protocol number: 19–152.

The Mice used in the study were euthanized post-infection, while the rabbits not euthanized or anesthetized and released after blood samples collection according the previous ethical approval. Also, the authors confirm that permission from the farmer was obtained for collecting fecal samples from newborn buffalo calves. All methods were carried out in accordance with relevant guidelines and regulations for the use of animal subjects. The study was carried out in compliance with the ARRIVE guidelines.

Consent for publication

Not applicable.

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Aboelsoued, D., Toaleb, N.I., Ibrahim, S. et al. A Cryptosporidium parvum vaccine candidate effect on immunohistochemical profiling of CD4+, CD8+, Caspase-3 and NF-κB in mice. BMC Vet Res 19, 216 (2023). https://0-doi-org.brum.beds.ac.uk/10.1186/s12917-023-03699-w

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://0-doi-org.brum.beds.ac.uk/10.1186/s12917-023-03699-w

Keywords

BMC Veterinary Research

ISSN: 1746-6148

Contact us